Germany
· Delayed Price · Currency is EUR Apontis Pharma AG Statistics
Total Valuation
FRA:APPH has a market cap or net worth of EUR 93.30 million. The enterprise value is 77.84 million.
| Market Cap | 93.30M |
| Enterprise Value | 77.84M |
Important Dates
The last earnings date was Wednesday, May 7, 2025.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 8.33M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.04M |
Valuation Ratios
The trailing PE ratio is 123.81 and the forward PE ratio is 26.66.
| PE Ratio | 123.81 |
| Forward PE | 26.66 |
| PS Ratio | 1.92 |
| PB Ratio | 3.01 |
| P/TBV Ratio | 4.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.67, with an EV/FCF ratio of -26.70.
| EV / Earnings | 103.30 |
| EV / Sales | 1.61 |
| EV / EBITDA | 22.67 |
| EV / EBIT | 65.15 |
| EV / FCF | -26.70 |
Financial Position
The company has a current ratio of 2.49
| Current Ratio | 2.49 |
| Quick Ratio | 1.70 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 10.39 |
Financial Efficiency
Return on equity (ROE) is 2.46% and return on invested capital (ROIC) is 2.22%.
| Return on Equity (ROE) | 2.46% |
| Return on Assets (ROA) | 1.47% |
| Return on Invested Capital (ROIC) | 2.22% |
| Return on Capital Employed (ROCE) | 3.39% |
| Revenue Per Employee | 353,777 |
| Profits Per Employee | 5,501 |
| Employee Count | 137 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 3.16 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.49% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +28.49% |
| 50-Day Moving Average | 10.93 |
| 200-Day Moving Average | 9.33 |
| Relative Strength Index (RSI) | 50.25 |
| Average Volume (20 Days) | 282 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:APPH had revenue of EUR 48.47 million and earned 753,569 in profits. Earnings per share was 0.09.
| Revenue | 48.47M |
| Gross Profit | 27.70M |
| Operating Income | 1.19M |
| Pretax Income | 1.13M |
| Net Income | 753,569 |
| EBITDA | 3.43M |
| EBIT | 1.19M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 15.45 million in cash and n/a in debt, giving a net cash position of 15.45 million.
| Cash & Cash Equivalents | 15.45M |
| Total Debt | n/a |
| Net Cash | 15.45M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 31.02M |
| Book Value Per Share | 3.72 |
| Working Capital | 13.63M |
Cash Flow
In the last 12 months, operating cash flow was -2.90 million and capital expenditures -14,607, giving a free cash flow of -2.92 million.
| Operating Cash Flow | -2.90M |
| Capital Expenditures | -14,607 |
| Free Cash Flow | -2.92M |
| FCF Per Share | n/a |
Margins
Gross margin is 57.16%, with operating and profit margins of 2.47% and 1.55%.
| Gross Margin | 57.16% |
| Operating Margin | 2.47% |
| Pretax Margin | 2.32% |
| Profit Margin | 1.55% |
| EBITDA Margin | 7.09% |
| EBIT Margin | 2.47% |
| FCF Margin | n/a |
Dividends & Yields
FRA:APPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.81% |
| FCF Yield | -3.12% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:APPH has an Altman Z-Score of 4.06.
| Altman Z-Score | 4.06 |
| Piotroski F-Score | n/a |